Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bullish
Legochem Biosciences
Watchlist
KRX New Deal Index Rebalance Preview: Smaller Deal Than Usual
Index Rebalance
1.2k Views
02 Feb 2025 21:50
Indications are for a smaller rebalance than usual as index performance suffers and AUM continues to shrink. There are some constituent changes plus a lot of capping changes.
What is covered in the Full Insight:
Introduction to KRX New Deal Index
Rebalance Review Period
Expected Changes Across Indices
Impact of Capping Changes
Conclusion
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 5-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Event-Driven
Index Rebalance
Equity Bottom-Up
Japan
South Korea
India
Philippines
Singapore
Asia ECM
Equity Derivatives
Trending Insights
More »
Yuanta/P-Shares Taiwan Div+ ETF Rebalance: Huge Turnover & Flow Overlap
Merger Arb Mondays (09 June) - Mayne, Tam Jai, OneConnect, Toyota Industries, Makino, Fuji Corp
[Japan M&A] Private Co Takeout of Fuji Corp (7605 JP) - A Done Deal
NIFTY200 Momentum30 Index Rebalance: HUGE Turnover and Trade as Financials Shine
Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
Top Unpaywalled Insights
More »
Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
[IO Technicals 2025/23] Bearish Momentum Persists
VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
[IO Technicals 2025/22] Bearish Momentum Strengthens
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
KRX New Deal Index Rebalance Preview: Potential Changes as Review Period Ends Today
30 Jul 2024
KRX New Deal Index Rebalance Preview: Douzone Bizon Does It Again
31 Jan 2024
KRX New Deal Index Rebalance Preview (March): More Flow for LG Energy
02 Feb 2022
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x